Skip to main navigation Skip to search Skip to main content

Mutations in CEP57 cause mosaic variegated aneuploidy syndrome

  • Katie Snape
  • , Sandra Hanks
  • , Elise Ruark
  • , Patricio Barros-Núñez
  • , Anna Elliott
  • , Anne Murray
  • , Andrew H. Lane
  • , Nora Shannon
  • , Patrick Callier
  • , David Chitayat
  • , Jill Clayton-Smith
  • , David R. Fitzpatrick
  • , David Gisselsson
  • , Sebastien Jacquemont
  • , Keiko Asakura-Hay
  • , Mark A. Micale
  • , John Tolmie
  • , Peter D. Turnpenny
  • , Michael Wright
  • , Jenny Douglas
  • Nazneen Rahman
  • The Institute of Cancer Research
  • Instituto Mexicano del Seguro Social
  • City Hospital
  • Université de Bourgogne
  • University of Toronto
  • Imperial College Healthcare NHS Trust
  • NHS Lothian
  • Lund University
  • University of Lausanne
  • University of Dundee
  • Oakland University
  • NHS Greater Glasgow and Clyde
  • Royal Devon & Exeter NHS Foundation Trust
  • Newcastle upon Tyne Hospitals NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Abstract

Using exome sequencing and a variant prioritization strategy that focuses on loss-of-function variants, we identified biallelic, loss-of-function CEP57 mutations as a cause of constitutional mosaic aneuploidies. CEP57 is a centrosomal protein and is involved in nucleating and stabilizing microtubules. Our findings indicate that these and/or additional functions of CEP57 are crucial for maintaining correct chromosomal number during cell division.

Original languageEnglish
Pages (from-to)527-529
Number of pages3
JournalNature Genetics
Volume43
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Dive into the research topics of 'Mutations in CEP57 cause mosaic variegated aneuploidy syndrome'. Together they form a unique fingerprint.

Cite this